XML 18 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statement of Cash Flows - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net Income (Loss) Attributable to Parent $ 865 $ 1,139
Adjustments to reconcile Net Income (Loss) to net cash provided by (used for) operating activities:    
Depreciation, amortization and accretion 1,301 1,315
Amortization of deferred financing costs and other non-cash interest 24 22
Stock-based compensation expense, net 108 126
Asset write-down charges 24 30
Deferred income tax (benefit) provision 5 1
Other non-cash adjustments, net 20 10
Changes in assets and liabilities, excluding the effects of acquisitions:    
Increase (decrease) in accrued interest (55) (38)
Increase (decrease) in accounts payable (13) (20)
Increase (decrease) in other liabilities (127) (162)
Decrease (increase) in receivables 69 87
Decrease (increase) in other assets (155) (252)
Net cash provided by (used for) operating activities 2,066 2,258
Cash flows from investing activities:    
Capital expenditures (946) (1,067)
Payments for acquisitions, net of cash acquired (8) (93)
Other investing activities, net 7 5
Net cash provided by (used for) investing activities (947) (1,155)
Cash flows from financing activities:    
Proceeds from issuance of long-term debt 1,244 2,347
Principal payments on debt and other long-term obligations (71) (58)
Purchases and redemptions of long-term debt (750) (750)
Borrowings under revolving credit facility 0 2,943
Payments under revolving credit facility (670) (4,088)
Net issuances (repayments) under commercial paper program 1,312 561
Payments for financing costs (12) (23)
Purchases of common stock (32) (29)
Dividends/distributions paid on common stock (2,049) (2,044)
Net cash provided by (used for) financing activities (1,028) (1,141)
Net increase (decrease) in cash and cash equivalents, and restricted cash and cash equivalents 91 (38)
Effect of Exchange Rate on Cash and Cash Equivalents and Restricted Cash and Cash Equivalents (1) 0
Cash and cash equivalents and restricted cash and cash equivalents at beginning of period 281 327
Cash and cash equivalents and restricted cash and cash equivalents at end of period $ 371 $ 289